Hamilton Lane HLNE 深 滬
等待開盤 11-04 09:30:00 美东时间
88.63
+0.790
+0.90%
華盛通- 最 高89.655
- 今 開87.825
- 成交量 79.75万股
- 最 低 83.54
- 昨 收 87.84
- 總市值 48.84亿
- 52周最高 153.92
- 市盈率 靜 14.97
- 換手率 1.45%
- 52周最低 71.28
- 委 比 -55.25%
- 總股本 5511.06万
- 歷史最高 199.38
- 量 比 1.46
- 振 幅 6.96%
- 歷史最低 3.32
- 每 手 1
- 風險率 20.88%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多财报速睇 | Hamilton Lane 2026财年Q3营收2.04亿美元，同比增长7.1%；归母净利润0.77亿美元，同比增长9.3%
华盛资讯11月4日讯，Hamilton Lane公布2026财年Q3业绩，公司Q3营收2.04亿美元，同比增长7.1%，归母净利润0.77亿美元，同比增长9.3%。
今天 08:49
Hamilton Lane Earnings Call Highlights Broad-Based Growth
Hamilton Lane Inc (($HLNE)) has held its Q2 earnings call. Read on for the main...
今天 08:28
财报速睇 | Hamilton Lane 2026财年Q3营收2.04亿美元，同比增长7.1%；归母净利润0.77亿美元，同比增长9.3%
华盛资讯11月3日讯，Hamilton Lane公布2026财年Q3业绩，公司Q3营收2.04亿美元，同比增长7.1%，归母净利润0.77亿美元，同比增长9.3%。
11-03 23:04
Hamilton Lane Q2 Adj. EPS $1.98 Beats $1.66 Estimate, Sales $204.430M Miss $221.157M Estimate
Hamilton Lane (NASDAQ:HLNE) reported quarterly earnings of $1.98 per share which beat the analyst consensus estimate of $1.66 by 19.28 percent. This is a 28.57 percent increase over earnings of $1.54 per share from the same period last year. The company reported quarterly sales of $204.430 million w...
11-03 20:29
HAMILTON LANE INCORPORATED REPORTS SECOND QUARTER FISCAL 2027 RESULTS
CONSHOHOCKEN, Pa., Nov. 3, 2026 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (Nasdaq: HLNE) today reported its results for the second fiscal quart...
11-03 20:00
美股大行评级 | 潜在涨幅94.81%！富瑞上调ArriVent BioPharma(AVBP)目标价至30美元，维持"买入"评级
今日重点评级关注：富瑞：维持ArriVent BioPharma"买入"评级，目标价从18美元升至30美元；古根海姆：维持第一太阳能"买入"评级，目标价从282美元升至299美元
10-28 12:30
BMO Capital Maintains Outperform on Hamilton Lane, Lowers Price Target to $95
BMO Capital analyst Brennan Hawken maintains Hamilton Lane (NASDAQ:HLNE) with a Outperform and lowers the price target from $116 to $95.
10-28 01:42
Hamilton Lane Incorporated Class A收涨3.46%，成交额7466.18万美元
10月23日，Hamilton Lane Incorporated Class A（HLNE）收涨3.46%，报85.31美元，成交额7466.18万美元，市值...
10-23 05:08
UBS Maintains Buy on Hamilton Lane, Lowers Price Target to $115
UBS analyst Michael Brown maintains Hamilton Lane (NASDAQ:HLNE) with a Buy and lowers the price target from $131 to $115.
10-14 05:15
